Fat Distribution in Healthy Early Postmenopausal Women

• Status: Completed
• Trial end date: 2004-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of this study is to explore the effects of hormone replacement therapy with EV/DNG on abdominal fat distribution measured by magnetic resonance imaging.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bayer
• Treatments: Estradiol Valerate, dienogest drug combination

Criteria

Inclusion Criteria:

• Healthy early postmenopausal women

• BMI between 25 and 30

Exclusion Criteria:

• Contra-indication(s) for hormone treatment

• Metabolic diseases

• Concomitant medication with influence on lipid metabolism